Table 5: Univariate and multivariate Cox proportional hazards analysis of the biological and clinicopathological features of prostate cancer predicting MFS in localized PCa patients.

Variable

Univariate analysis

Multivariate analysis

RR

95% CI

p value*

RR

95% CI

value

Age (years)

 

 

 

 

 

 

≤ 67.0

1.00

Reference

 

 

 

 

> 67.0

1.59

0.52-4.86

0.416

 

 

 

PSA

 

 

 

 

 

 

≤ 10.2 ng/mL

1.00

Reference

 

 

 

 

> 10.2 ng/mL

1.32

1.22-11.47

0.020

 

 

 

AJCC Grade

 

 

 

 

 

 

1-3

1.00

Reference

 

 

 

 

4-5

3.83

1.05-13.97

0.041

 

 

 

Clinical stage

 

 

 

 

 

 

cT1-2

1.00

Reference

0.051

 

 

 

cT3-4

3.04

0.99-9.30

 

 

 

 

Pathological stage

 

 

 

 

 

 

pT1-2

1.00

Reference

 

 

 

 

pT3-4

3.08

1.01-9.43

0.048

 

 

 

Radical surgery

 

 

 

 

yes

0.57

0.19-1.68

0.307

 

 

 

no

1.00

Reference

 

 

 

 

Hist-pat surgical margins

 

 

 

 

 

 

negative

1.00

Reference

 

 

 

 

positive

1.06

0.36-3.17

0.910

 

 

 

Seminal vesicle(s) invasion

 

 

 

 

 

 

negative

1.00

Reference

0.010

1.00

Reference

0.007

positive

4.15

1.39-12.36

 

4.48

1.50 – 13.34

 

Adjuvant treatment

 

 

 

 

 

 

no

1.00

Reference

 

 

 

 

yes

2.20

0.7-6.7

0.165

 

 

 

Ki-67LI

 

 

 

 

 

 

≤ 18.0 %

1.00

Reference

 

 

 

 

> 18.0 %

4.84

1.33-17.8

0.017

 

 

 

GLUT-1LI

 

 

 

 

 

 

≤ 19.1 %

1.00

Reference

 

 

 

 

> 19.1 %

2.40

0.66-8.71

0.183

 

 

 

VEGF LI

 

 

 

 

 

 

≤ 11.0 %

1.00

Reference

 

 

 

 

> 11.0 %

0.47

0.14-1.52

0.209

 

 

 

MVD

 

 

 

 

 

 

≤ 94.2/mm2

1.00

Reference

 

 

 

 

> 94.2/mm2

1.10

0.34-3.57

0.876

 

 

 

PSMA LI

 

 

 

 

 

 

≤ 76.7 %

1.00

Reference

 

 

 

 

> 76.7 %

2.72

0.60-12.30

0.193

 

 

 

hTERT LI

 

 

 

 

 

 

≤ 43.8 %

1.00

Reference

 

1.00

Reference

 

> 43.8 %

0.23

0.07-0.75

0.015

0.22

0.07-0.71

0.011

RR: risk ratio, CI: confidence interval.